Fast Five Quiz: Test Your Knowledge of Systemic Treatment for Metastatic Breast Cancer

Winston W. Tan, MD; Stefania Morganti, MD


March 14, 2023

Breast cancer is the most common type of cancer, excluding nonmelanoma skin cancer, and the second leading cause of cancer-related deaths among women in the United States, after lung cancer. An estimated 287,850 new cases of breast cancer are expected to be diagnosed in the US in 2022. Furthermore, 43,250 deaths from breast cancer are expected in the US in the same year. More than 91% of breast cancer deaths occur in patients 50 years of age or older, and half of these deaths occur in those 70 years of age or older. Approximately 4% of patients with breast cancer in the US have metastatic disease in 2022. Although options for treating metastatic breast cancer continue to expand and improve, advanced disease remains essentially incurable.

Locoregional therapies, such as surgery and radiation, target disease in a specific area by removing it or shrinking it. In general, recurrent or metastatic breast cancer must be approached systemically so that the therapeutic effect reaches all sites of disease. These systemic approaches may include hormone therapy, chemotherapy, targeted therapy, immunotherapy, or combinations.

How much do you know about systemic treatment for metastatic breast cancer? Test your knowledge with this quick quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.